Actively Recruiting
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
Led by Northwell Health · Updated on 2026-02-04
50
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, descriptive study. Safety endpoints will not be assessed. All eligible patients that have a history of paroxysmal atrial fibrillation and an indication to undergo Micra AV2 device placement as per standard of care (SOC) across the participating sites within the Northwell Health System can be included in this analysis. Micra AV2 placement indications will be at the discretion of the treating electrophysiologist, but are expected to be predominantly atrioventricular block. Periodic device interrogations will be reviewed for the presence of effective atrial tracking during sinus rhythm . The presence of paroxysmal atrial fibrillation and the degree to which atrial activity and A4 amplitude trend changes will be assessed using a designated Medtronic Research Holter monitor that detects Micra AV2 signals at any point in the study during a episodes of sinus rhythm and atrial fibrillation. Patients who have atrial fibrillation during index hospitalization will undergo placement of the Medtronic Holter monitor as part of the standard of care index hospitalization. Eligible outpatients will undergo placement of the Medtronic Research Holter Monitor in the office.
CONDITIONS
Official Title
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant or legally authorized representative provides consent per institution and geographical requirements
- Participant has been or will be implanted with the Micra AV2 device as part of standard care
- Participant has a history of paroxysmal atrial fibrillation and is undergoing Micra AV2 implantation
- Age between 18 and 85 years old and able to consent to the procedure
- Participant is consented within the enrollment window related to therapy received
- Participant is English speaking
You will not qualify if you...
- Participant is or is expected to be inaccessible for follow-up
- Participation is prohibited by local law
- Participant is currently enrolled or plans to enroll in another drug or device study that could affect results
- Participant has persistent or chronic atrial fibrillation
- Participant is a prisoner or cognitively impaired and unable to independently wear the Holter monitor for research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Long Island Jewish Medical Center
New Hyde Park, New York, United States, 11040
Actively Recruiting
Research Team
S
Salome Elia Reddy, PhD
CONTACT
E
Emma Grace Lao
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here